{"schema_version":"secwatch.filing_event.v1","accession":"0001121702-24-000019","form_type":"8-K","ticker":null,"cik":"0001121702","company_name":"YIELD10 BIOSCIENCE, INC.","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:17.355661+00:00","generated_at":"2026-06-04T04:20:17.731975+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Yield10 posts $14.5M net loss in 2023; licenses Camelina to Vision for $3M","bullets":["Full-year 2023 net loss $14.5M ($1.82/share) vs $13.6M ($2.76/share) in 2022.","Ended 2023 with $1.1M cash; used $10.1M in operations; raised $1.2M net via warrant inducement in Mar 2024.","Granted Vision Bioenergy global license for Camelina biofuel feedstock; $3M cash payments for license.","USDA-APHIS cleared omega-3 traits; CFIA cleared E3902 (oil yield +5%) for planting in Canada.","Omega-3 Camelina targeted for aquafeed; potential revenue as early as 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001121702-24-000019","json":"https://secwatch.observer/filing/0001121702-24-000019.json","markdown":"https://secwatch.observer/filing/0001121702-24-000019.md","text":"https://secwatch.observer/filing/0001121702-24-000019.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000019/0001121702-24-000019-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000019/yten-20240401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:20:17.731975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"ef950749767c7c20e82eeb9782fdbfbdeec6a485","claim":"YIELD10 BIOSCIENCE, INC. reported financial results for the fourth quarter and full year ended December 31, 2023.","evidence_excerpt":"On April 1, 2024 , Yield10 Bioscience, Inc. issued a press release announcing the financial results for the quarter and fiscal year ended December 31, 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1121702/000112170224000019/0001121702-24-000019-index.htm","confidence":0.8,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter and full year ended December 31, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}